CJC-1295 vs Ipamorelin: What’s the Difference?
What Is CJC-1295?
CJC-1295 is a growth hormone–releasing hormone (GHRH) analog designed to stimulate sustained endogenous growth hormone secretion through pituitary activation.
What Is Ipamorelin?
Ipamorelin is a selective ghrelin mimetic that triggers short, pulsatile growth hormone release while minimizing stimulation of cortisol and prolactin.
Key Differences at a Glance
| Feature | CJC-1295 | Ipamorelin |
|---|---|---|
| Peptide Class | GHRH Analog | Ghrelin Mimetic |
| Half-Life | Long | Short |
| GH Release | Sustained | Pulsatile |
Why Are CJC-1295 and Ipamorelin Often Combined?
When studied together, these peptides activate complementary growth hormone pathways, producing a broader and more physiologically relevant GH response.
Research Product Examples
Frequently Asked Questions
What is the main difference between CJC-1295 and Ipamorelin?
CJC-1295 provides long-lasting GH signaling, while Ipamorelin produces short GH pulses.
Can CJC-1295 and Ipamorelin be studied together?
Yes, they are frequently researched together due to complementary mechanisms.
FTC Disclosure: Some links on this page are affiliate links. This means
Peptide News may earn a commission if you choose to make a purchase through those links,
at no additional cost to you.
Disclaimer: This content is for informational purposes only. Products referenced
are sold for research use only and are not intended for human consumption.
Visit Peptide-News.com
Beginner’s Guide to Peptides
New to peptides? Check out our comprehensive beginner’s guide to understand what peptides are, how they work, and why researchers and enthusiasts are exploring them for health, recovery, and performance.
Leave a Reply